Get the Stockscreener App
24.39
0.37%
0.0899
Astrana Health Inc stock is traded at $24.39, with a volume of 7,168.
It is up +0.37% in the last 24 hours and up +17.50% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$24.48
Open:
$24.34
24h Volume:
7,168
Relative Volume:
0.01
Market Cap:
$1.36B
Revenue:
$3.18B
Net Income/Loss:
$24.08M
P/E Ratio:
53.48
EPS:
0.4561
Net Cash Flow:
$104.49M
1W Performance:
+1.61%
1M Performance:
+17.50%
6M Performance:
-17.22%
1Y Performance:
-20.20%
1-Day Range:
$24.20
$24.41
1-Week Range:
$23.00
$25.41
52-Week Range:
$18.08
$34.80
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
24.39 | 1.36B | 3.18B | 24.08M | 104.49M | 0.4561 |
HCA
Hca Healthcare Inc
|
487.75 | 108.21B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
200.17 | 17.40B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.27 | 12.43B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
204.59 | 11.85B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
187.53 | 11.41B | 17.36B | 1.51B | 849.25M | 23.15 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Healthcare Technology for Providers Stocks Q4 Recap: Benchmarking Astrana Health (NASDAQ:ASTH) - Yahoo Finance
If You Invested $1,000 in Astrana Health (ASTH) - Stock Titan
Is It Time To Reassess Astrana Health (ASTH) After Its Recent 22% Share Price Jump - Yahoo Finance
Astrana Health, Inc. (NASDAQ:ASTH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Block Trades: Is Astrana Health Inc impacted by rising ratesGDP Growth & Verified Short-Term Plans - baoquankhu1.vn
Targets Report: How does Astrana Health Inc. perform in inflationary periodsWeekly Investment Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Insight Wealth Strategies LLC Purchases New Position in Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health outlines $3.8B–$4.1B 2026 revenue target amid continued full-risk expansion and operating leverage - MSN
Astrana Health, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Astrana Health (ASTH) Q4 2025 Earnings Transcript - AOL.com
Astrana Health, Inc. $ASTH is 325 Capital LLC's 4th Largest Position - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Astrana Health (NASDAQ:ASTH) Price Target Raised to $38.00 at Truist Financial - MarketBeat
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $38Astrana Health (NASDAQ:ASTH) - Benzinga
Truist raises Astrana Health stock price target on earnings update By Investing.com - Investing.com South Africa
Truist raises Astrana Health stock price target on earnings update - Investing.com Nigeria
Astrana Health (NASDAQ:ASTH) Raised to "Hold" at Zacks Research - MarketBeat
OBBBA Threatens Astrana Health’s Revenue as Tighter Eligibility Rules Shrink Federally Funded Patient Base - TipRanks
Decoding Astrana Health Inc (ASTH): A Strategic SWOT Insight - GuruFocus
A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns - simplywall.st
Astrana Health reports $3.18B revenue, $0.46 EPS in 10-K - TradingView
Astrana Health CEO Sees 20%-30% Growth in 2026 Despite Regulatory Volatility at Barclays Conference - MarketBeat
Can Astrana Health Inc sustain earnings growthMarket Growth Report & Momentum Based Trading Signals - baoquankhu1.vn
Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades - Fidelity
Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award from Healthgrades - Finviz
Astrana Health (NASDAQ:ASTH) Shares Down 4.9%Here's Why - MarketBeat
Astrana Health, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
[Form 4] Astrana Health, Inc. Insider Trading Activity - Stock Titan
Astrana Health (ASTH) CMO surrenders shares for equity tax withholding - Stock Titan
Astrana Health (ASTH) Is Up 22.5% After Earnings Beat, Buyback Boost and 10-K DelayHas The Bull Case Changed? - Sahm
Astrana Health Buyback Expansion And Control Weakness Create Key Turning Point - Sahm
Astrana Health initiated as buy at Needham on valuation - MSN
Investment Report: Is Astrana Health Inc a cyclical or defensive stockJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn
Astrana Health Updates Investor Presentation on Value-Based Strategy - The Globe and Mail
Astrana Health, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations - Markets Mojo
Royce & Associates LP Reduces Stock Holdings in Astrana Health, Inc. $ASTH - MarketBeat
ASTH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Astrana Health (ASTH) Still Attractive After The Recent 28% Weekly Price Jump - simplywall.st
Vanguard Group Inc. Sells 112,308 Shares of Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health : Investor Presentation – March 2026 - marketscreener.com
Astrana Health updates corporate presentation, reiterates FY2026 revenue $3.8–4.1B and Adj. EBITDA $250–280M guidance - TradingView
Astrana Health (NASDAQ: ASTH) issues 2026 growth guidance and flags control weakness - Stock Titan
Cigna CEO Cordani To Retire, Successor Named At Bloomfield-Based Health Care Giant - AOL.com
Astrana Health (ASTH +29%): Massive EPS Beat & Strong 2026 Guidance Ignites Rally - Trefis
Astrana Health to Attend Investor Conferences in March 2026 - geneonline.com
Doctor-focused Astrana Health lines up five investor talks in March - Stock Titan
Astrana Health Posts Upbeat Q4 Earnings, Joins AeroVironment, Kratos Defense & Security Solutions And Other Big Stocks Moving Higher On Monday - Sahm
Astrana Health Inc. (ASTH) - DirectorsTalk Interviews
Astrana Health Juggles Profit Turnaround Buybacks And 10 K Delay - Yahoo Finance
Needham raises Astrana Health stock price target to $30 on outlook - Investing.com UK
Astrana Health raises share repurchase authorization to $100M - TipRanks
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
0.51%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):